Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States

被引：0
作者：
Sunnie Kim
James E. Signorovitch
Hongbo Yang
Oscar Patterson-Lomba
Cheryl Q. Xiang
Brian Ung
Monika Parisi
John L. Marshall
机构：
[1] MedStar Georgetown University Hospital,Ruesch Center for the Cure of GI Cancers
[2] Analysis Group,undefined
[3] Inc.,undefined
[4] Celgene Corporation,undefined
[5] Georgetown University,undefined
[6] Lombardi Comprehensive Cancer Center,undefined
来源：
Advances in Therapy | 2018年 / 35卷
关键词：
Adverse events; FOLFIRINOX; Metastatic adenocarcinoma of the pancreas; nab-Paclitaxel; Real-world evidence; Survival analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1564 / 1577
页数：13
相关论文
共 58 条
[31]  
Kavan P(undefined)undefined undefined undefined undefined-undefined
[32]  
Chan K(undefined)undefined undefined undefined undefined-undefined
[33]  
Shah K(undefined)undefined undefined undefined undefined-undefined
[34]  
Lien K(undefined)undefined undefined undefined undefined-undefined
[35]  
Gharaibeh M(undefined)undefined undefined undefined undefined-undefined
[36]  
McBride A(undefined)undefined undefined undefined undefined-undefined
[37]  
Bootman JL(undefined)undefined undefined undefined undefined-undefined
[38]  
Cranmer LD(undefined)undefined undefined undefined undefined-undefined
[39]  
Abraham I(undefined)undefined undefined undefined undefined-undefined
[40]  
Cartwright TH(undefined)undefined undefined undefined undefined-undefined
123456